Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05663502 · ClinicalTrials.gov registry record
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
A clinical trial of Lymphoma and Malignant Solid Neoplasm, sponsored by AIDS Malignancy Consortium.
- Recruiting
- Registry status
- 200
- Enrollment target
- 8
- Study locations
NCT05663502 is a study of Lymphoma and Malignant Solid Neoplasm that is actively recruiting participants, run by AIDS Malignancy Consortium. The registered enrollment target is 200 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (59% lower). The trial reports 8 study locations across 6 states.
The verdict
NCT05663502, a study of Lymphoma and Malignant Solid Neoplasm, is actively recruiting participants, sponsored by AIDS Malignancy Consortium.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors related to HIV and cancers that occur commonly in people living with HIV.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
Study Locations (8)
California
- UC San Diego Moores Cancer Center - La Jolla
- University of California, San Francisco - San Francisco
New York
- Mount Sinai Hospital - New York
- Memorial Sloan Kettering Cancer Center - New York
District of Columbia
- George Washington University - Washington D.C.
Florida
- University of Miami - Miami
Maryland
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins - Baltimore
Utah
- Huntsman Cancer Institute, University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-05-10 |
| Est. Completion | 2035-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05663502
The ClinicalTrials.gov registry entry for NCT05663502 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (59% lower). The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection is the first listed.
NCT05663502 reports 8 study locations spanning 6 distinct geographic areas - top geographies include California, New York, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05663502 about?
NCT05663502 is a clinical study titled "Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers". This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors relat...
What is the current status of trial NCT05663502?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-05-10. Estimated completion is 2035-08-31.
What conditions does trial NCT05663502 study?
This clinical trial studies the following conditions: Lymphoma, Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, HIV Infection, Kaposi Sarcoma.
What interventions are being tested in trial NCT05663502?
The interventions under investigation include: Biospecimen Collection (PROCEDURE).
Who is sponsoring clinical trial NCT05663502?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05663502 being conducted?
This trial has 8 study locations across California, District of Columbia, Florida, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.